As reported, the combination of the GSTM1 null, GSTT1 null, and GSTP1 AA genotypes was associated with an increased risk of gynecological cancer, while the GSTs alone were not.[23] Therefore, gene–gene interactions are likely more appropriate to assess disease risk than individual genes. The gene discussed is GSTP1; the disease is female reproductive organ cancer.